Safety and Pharmacokinetics Study in Healthy Japanese Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

February 18, 2022

Study Completion Date

February 18, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

ABX464

Drug: ABX464 ABX464 is a new anti-inflammatory drug

DRUG

Placebo

Drug: Matching Placebo placebo matching with ABX464

Trial Locations (1)

Medical Corporation Heishinkai OPHAC Hospital, Osaka